Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Amir Kalani, James H. Tabibian & Keith D. Lindor. (2018) Emerging therapeutic targets for primary sclerosing cholangitis. Expert Opinion on Orphan Drugs 6:7, pages 393-401.
Read now
Read now
Stephen J Merrill, Samira Ashrafi, Madhan Subramanian & Dianne E Godar. (2015) Exponentially increasing incidences of cutaneous malignant melanoma in Europe correlate with low personal annual UV doses and suggests 2 major risk factors. Dermato-Endocrinology 7:1.
Read now
Read now
Sinead Field, John Davies, D. Tim Bishop & Julia A. Newton-Bishop. (2013) Vitamin D and melanoma. Dermato-Endocrinology 5:1, pages 121-129.
Read now
Read now
Paulina Szyszka, Michal A Zmijewski & Andrzej T Slominski. (2012) New vitamin D analogs as potential therapeutics in melanoma. Expert Review of Anticancer Therapy 12:5, pages 585-599.
Read now
Read now
Dianne E. Godar, Stanley J. Pope, William B. Grant & Michael F. Holick. (2011) Solar UV Doses of Adult Americans and Vitamin D3 Production. Dermato-Endocrinology 3:4, pages 243-250.
Read now
Read now
Pit Sertznig, Markus Seifert, Wolfgang Tilgen & Jörg Reichrath. (2009) Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)2D3 in melanoma cell lines and other skin-derived cell lines. Dermato-Endocrinology 1:4, pages 232-238.
Read now
Read now
John A Halsall, Joy E Osborne, Michael P Epstein, James H Pringle & Peter E Hutchinson. (2009) The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma. Dermato-Endocrinology 1:1, pages 54-57.
Read now
Read now
Articles from other publishers (45)
Jörg Reichrath & Michael F. Holick. 2024. Feldman and Pike's Vitamin D. Feldman and Pike's Vitamin D
1207
1230
.
Juliana Polizel Ocanha Xavier, José Cândido Caldeira XavierMárcia Guimarães da SilvaMariângela Esther Alencar Marques. (2023) Vitamin D Receptor and Retinoid X Receptor Alpha in Melanocytic Benign Lesions and Melanoma. The American Journal of Dermatopathology 45:9, pages 619-625.
Crossref
Crossref
Tania F. Cestari, Marcel de Almeida Dornelles & Sérgio Ivan Torres Dornelles. 2023. Dermatology in Public Health Environments. Dermatology in Public Health Environments
827
844
.
Jörg Reichrath, Florian Biersack, Stefan Wagenpfeil, Jakob Schöpe, Claudia Pföhler, Roman Saternus & Thomas Vogt. (2022) Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Anna Piotrowska, Fernando Pereira Beserra, Justyna Marta Wierzbicka, Joanna Irena Nowak & Michał Aleksander Żmijewski. (2021) Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells. Frontiers in Oncology 11.
Crossref
Crossref
Sachin Bhoora & Rivak Punchoo. (2020) Policing Cancer: Vitamin D Arrests the Cell Cycle. International Journal of Molecular Sciences 21:23, pages 9296.
Crossref
Crossref
Jo S. Stenehjem, Nathalie C. Støer, Reza Ghiasvand, Tom K. Grimsrud, Ronnie Babigumira, Judy R. Rees, Lill Tove Nilsen, Bjørn Johnsen, Per M. Thorsby, Marit B. Veierød & Trude E. Robsahm. (2020) Prediagnostic serum 25-hydroxyvitamin D and melanoma risk. Scientific Reports 10:1.
Crossref
Crossref
Neda Vishlaghi & Thomas S. Lisse. (2020) Exploring vitamin D signalling within skin cancer. Clinical Endocrinology 92:4, pages 273-281.
Crossref
Crossref
Peter E. Hutchinson, John A. Halsall, Silvia Popovici, Eftychios Papadogeorgakis, Joy E. Osborne, Ian R. Powley, Deepthi Dasari, Gerald Saldanha & James H. Pringle. (2018) Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity. Melanoma Research 28:5, pages 410-422.
Crossref
Crossref
Ewa Podgorska, Agnieszka Drzal, Zenon Matuszak, Jan Swakon, Andrzej Slominski, Martyna Elas & Krystyna Urbanska. (2018) Calcitriol and Calcidiol Can Sensitize Melanoma Cells to Low–LET Proton Beam Irradiation. International Journal of Molecular Sciences 19:8, pages 2236.
Crossref
Crossref
Andrew C. Walls & Martin A. Weinstock. 2018. The American Cancer Society's Principles of Oncology. The American Cancer Society's Principles of Oncology
99
109
.
Jörg Reichrath & Michael F. Holick. 2018. Vitamin D. Vitamin D
1037
1051
.
Sérgio Ivan Torres Dornelles, Renan Rangel Bonamigo, Lúcio de Almeida Dornelles & Marcel de Almeida Dornelles. 2018. Dermatology in Public Health Environments. Dermatology in Public Health Environments
595
608
.
Andrzej T Slominski, Anna A Brożyna, Michal A Zmijewski, Wojciech Jóźwicki, Anton M Jetten, Rebecca S Mason, Robert C Tuckey & Craig A Elmets. (2017) Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management. Laboratory Investigation 97:6, pages 706-724.
Crossref
Crossref
Ahmad A. TarhiniPaul LoriganSancy Leachman. (2017) Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy. American Society of Clinical Oncology Educational Book:37, pages 651-660.
Crossref
Crossref
Lucia Spath, Alessandra Ulivieri, Luca Lavra, Laura Fidanza, Marta Carlesimo, Maria Giubettini, Alessandra Narcisi, Emidio Luciani, Barbara Bucci, Daniela Pisani, Salvatore Sciacchitano & Armando Bartolazzi. (2017) Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications. Scientific Reports 7:1.
Crossref
Crossref
Jörg Reichrath, Christos C. Zouboulis, Thomas Vogt & Michael F. Holick. (2016) Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook. Reviews in Endocrine and Metabolic Disorders 17:3, pages 405-417.
Crossref
Crossref
Luigi Francesco Morrone, Pergiorgio Bolasco, Corrado Camerini, Giuseppe Cianciolo, Adamasco Cupisti, Andrea Galassi, Sandro Mazzaferro, Domenico Russo, Luigi Russo & Mario Cozzolino. (2016) Vitamin D in patients with chronic kidney disease: a position statement of the Working Group “Trace Elements and Mineral Metabolism” of the Italian Society of Nephrology. Journal of Nephrology 29:3, pages 305-328.
Crossref
Crossref
Shenying Fang, Dawen Sui, Yuling Wang, Huey Liu, Yi-Ju Chiang, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, Richard E. Royal, Anthony Lucci, Jennifer Wargo, Mimi I. Hu, Julie M. Gardner, John D. Reveille, Roland L. Bassett, Qingyi Wei, Christopher I. Amos & Jeffrey E. Lee. (2016) Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein. Journal of Clinical Oncology 34:15, pages 1741-1747.
Crossref
Crossref
Syed Jalal Khundmiri, Rebecca D. Murray & Eleanor Lederer. 2011. Comprehensive Physiology. Comprehensive Physiology
561
601
.
J.M. WIERZBICKA, A. BINEK, T. AHRENDS, J.D. NOWAC KA, A. SZYDŁOWSKA, Ł. TURCZYK, T. WĄSIEWICZ, P.M. WIERZBICKI, R. SĄDEJ, R.C. TUCKEY, A.T. SLOMINSKI, J. CHYBICKI, K. ADRYCH, Z. KMIEĆ & M.A. ŻMIJEWSKI. (2015) Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture. International Journal of Oncology 47:3, pages 1084-1096.
Crossref
Crossref
Irene Russo, Francesca Caroppo & Mauro Alaibac. (2015) Vitamins and Melanoma. Cancers 7:3, pages 1371-1387.
Crossref
Crossref
Julia A. Newton‐Bishop, John R. Davies, Faheem Latheef, Juliette Randerson‐Moor, May Chan, Jo Gascoyne, Saila Waseem, Susan Haynes, Charles O'Donovan & D. Timothy Bishop. (2014)
25‐Hydroxyvitamin D
2
/D
3
levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort
. International Journal of Cancer 136:12, pages 2890-2899.
Crossref
Crossref
Candy Wyatt, Robyn M. Lucas, Cameron Hurst & Michael G. Kimlin. (2015) Vitamin D Deficiency at Melanoma Diagnosis Is Associated with Higher Breslow Thickness. PLOS ONE 10:5, pages e0126394.
Crossref
Crossref
Candy Wyatt, Rachel E Neale & Robyn M Lucas. (2015) Skin cancer and vitamin D: an update. Melanoma Management 2:1, pages 51-61.
Crossref
Crossref
Anna Brożyna, Cezary Jochymski, Zorica Janjetovic, Wojciech Jóźwicki, Robert Tuckey & Andrzej Slominski. (2014) CYP24A1 Expression Inversely Correlates with Melanoma Progression: Clinic-Pathological Studies. International Journal of Molecular Sciences 15:10, pages 19000-19017.
Crossref
Crossref
Monica Gelzo, Giuseppina Granato, Francesco Albano, Alessandro Arcucci, Antonio Dello Russo, Emmanuele De Vendittis, Maria Rosaria Ruocco & Gaetano Corso. (2014) Evaluation of cytotoxic effects of 7-dehydrocholesterol on melanoma cells. Free Radical Biology and Medicine 70, pages 129-140.
Crossref
Crossref
Anna A. Brożyna, Wojciech Jóźwicki, Zorica Janjetovic & Andrzej T. Slominski. (2013) Expression of the vitamin D–activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression. Human Pathology 44:3, pages 374-387.
Crossref
Crossref
Emanuela Micu, Zivile Baturaite, Asta Juzeniene, Øyvind S. Bruland & Johan E. Moan. (2012) Superficial-spreading and nodular melanomas in Norway. Melanoma Research 22:6, pages 460-465.
Crossref
Crossref
Jean Y. Tang, Teresa Fu, Christopher Lau, Dennis H. Oh, Daniel D. Bikle & Maryam M. Asgari. (2012) Vitamin D in cutaneous carcinogenesis. Journal of the American Academy of Dermatology 67:5, pages 817.e1-817.e11.
Crossref
Crossref
Dianne Eyvonn Godar, Stanley James Pope, William Burgess Grant & Michael Francis Holick. (2012)
Solar UV Doses of Young Americans and Vitamin D
3
Production
. Environmental Health Perspectives 120:1, pages 139-143.
Crossref
Crossref
Mai Ishibashi, Mariko Arai, Sachiko Tanaka, Kenji Onda & Toshihiko Hirano. (2012) Antiproliferative and Apoptosis-Inducing Effects of Lipophilic Vitamins on Human Melanoma A375 Cells in Vitro. Biological and Pharmaceutical Bulletin 35:1, pages 10-17.
Crossref
Crossref
SubbaRao V. Madhunapantula & Gavin P. Robertson. 2012. Current Challenges in Personalized Cancer Medicine. Current Challenges in Personalized Cancer Medicine
361
398
.
Ji H. Lee, Sunyoung Park, Soyoung Cheon, Joo H. Lee, Sunghan Kim, Dae Y. Hur, Tae S. Kim, Suk R. Yoon, Yoolhee Yang, Sa I. Bang, Hyunjeong Park, Hoon T. Lee & Daeho Cho. (2011)
1,25‐Dihydroxyvitamin D
3
enhances NK susceptibility of human melanoma cells via Hsp60‐mediated FAS expression
. European Journal of Immunology 41:10, pages 2937-2946.
Crossref
Crossref
Anna A. Brożyna, Wojciech Jozwicki, Zorica Janjetovic & Andrzej T. Slominski. (2011) Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Human Pathology 42:5, pages 618-631.
Crossref
Crossref
Sinead Field & Julia A. Newton-Bishop. (2011) Melanoma and vitamin D. Molecular Oncology 5:2, pages 197-214.
Crossref
Crossref
Fatouma Alimirah, Xinjian Peng, Genoveva Murillo & Rajendra G. Mehta. (2011) Functional Significance of Vitamin D Receptor FokI Polymorphism in Human Breast Cancer Cells. PLoS ONE 6:1, pages e16024.
Crossref
Crossref
Dianne E. Godar. (2011) Worldwide Increasing Incidences of Cutaneous Malignant Melanoma. Journal of Skin Cancer 2011, pages 1-6.
Crossref
Crossref
Jörg Reichrath & Michael F. Holick. 2011. Vitamin D. Vitamin D
1891
1903
.
Joel Pinczewski & Andrzej Slominski. (2010) The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms. Experimental Dermatology 19:10, pages 860-864.
Crossref
Crossref
Peter E. Hutchinson, Joy E. Osborne & James H. Pringle. (2010)
Higher Serum 25-Hydroxy Vitamin D
3
Levels at Presentation Are Associated With Improved Survival From Melanoma, But There Is No Evidence That Later Prevailing Levels Are Protective
. Journal of Clinical Oncology 28:27, pages e492-e493.
Crossref
Crossref
Ritchie Rosso, Nancy Kim & Robert S. Kirsner. (2009) Vitamin D Intake and Melanoma Risk. Journal of Investigative Dermatology 129:7, pages 1598.
Crossref
Crossref
Maryam M. Asgari, Sonia S. Maruti, Lawrence H. Kushi & Emily White. (2009) A Cohort Study of Vitamin D Intake and Melanoma Risk. Journal of Investigative Dermatology 129:7, pages 1675-1680.
Crossref
Crossref
B.H. Thiers. (2009) Vitamin D Receptor Polymorphisms and the Risk of Cutaneous Melanoma: A Systematic Review and Meta-Analysis. Yearbook of Dermatology and Dermatologic Surgery 2009, pages 372-373.
Crossref
Crossref
Simone Mocellin & Donato Nitti. (2008) Vitamin D receptor polymorphisms and the risk of cutaneous melanoma. Cancer 113:9, pages 2398-2407.
Crossref
Crossref